Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vitamin D Supplementation and Anti-resorptive Therapy (Bisphosphonates) Treatment of Young Adult Patients With Sickle Cell Disease

NCT02972138 is registered in ClinicalTrials.gov with Società Italiana Talassemie ed Emoglobinopatie as lead sponsor.

NCT NCT02972138
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02972138 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vitamin D Supplementation and Anti-resorptive Therapy (Bisphosphonates) Treatment of Young Adult Patients With Sickle Cell Disease
Lead sponsor
Società Italiana Talassemie ed Emoglobinopatie
Phase
Observational
Overall status
Completed
Start date
January 31, 2010
Completion date
September 30, 2017
Enrollment
80 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cells disease